Ceribell, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Ceribell, Inc.
- Regulatory records
- 5
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 5 FDA records to the applicant name Ceribell, Inc.. The collection includes 5 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Feb 9, 2026 to Sep 16, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code GXY appears in 2 of the 5 linked filings. The collection spans 4 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 360 N. Pastoria Ave., Sunnyvale, CA, 94085, US. Recorded on K261712, decision dated Sep 16, 2026.
Device categories in this collection
Non-Normalizing Quantitative Electroencephalograph Software; Reduced- Montage Standard Electroencephalograph; Automatic Event Detection Software For Full-Montage Electroencephalograph; Electrode, Cutaneous.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Ceribell EEG Analysis Software
K261712 · 510(k) clearanceCeribell Monitor
K261101 · 510(k) clearanceCeribell Neurology Review Software
K260998 · 510(k) clearanceCeribell Brain Monitor Headband
K260363 · 510(k) clearanceCeribell Instant EEG Headset
K254033 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.